% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Deng:273937,
author = {Deng, Yushuang and Liu, Ting and Scifo, Enzo and Li, Tao
and Xie, Kan and Taschler, Bernd and Morsy, Sarah and
Schaaf, Kristina and Ehninger, Armin and Bano, Daniele and
Ehninger, Dan},
title = {{A}nalysis of the senescence-associated cell surfaceome
reveals potential senotherapeutic targets.},
journal = {Aging cell},
volume = {23},
number = {12},
issn = {1474-9718},
address = {Oxford [u.a.]},
publisher = {Wiley-Blackwell},
reportid = {DZNE-2024-01411},
pages = {e14312},
year = {2024},
abstract = {The accumulation of senescent cells is thought to play a
crucial role in aging-associated physiological decline and
the pathogenesis of various age-related pathologies.
Targeting senescence-associated cell surface molecules
through immunotherapy emerges as a promising avenue for the
selective removal of these cells. Despite its potential, a
thorough characterization of senescence-specific surface
proteins remains to be achieved. Our study addresses this
gap by conducting an extensive analysis of the cell surface
proteome, or 'surfaceome', in senescent cells, spanning
various senescence induction regimes and encompassing both
murine and human cell types. Utilizing quantitative mass
spectrometry, we investigated enriched cell surface proteins
across eight distinct models of senescence. Our results
uncover significant changes in surfaceome expression
profiles during senescence, highlighting extensive
modifications in cell mechanics and extracellular matrix
remodeling. Our research also reveals substantive
heterogeneity of senescence, predominantly influenced by
cell type and senescence inducer. A key discovery of our
study is the identification of four unique cell surface
proteins with extracellular epitopes. These proteins are
expressed in senescent cells, absent or present at low
levels in their proliferating counterparts, and notably
upregulated in tissues from aged mice and an Alzheimer's
disease mouse model. These proteins stand out as promising
candidates for senotherapeutic targeting, offering potential
pathways for the detection and strategic targeting of
senescent cell populations in aging and age-related
diseases.},
keywords = {Cellular Senescence: drug effects / Animals / Humans / Mice
/ Senotherapeutics: pharmacology / Aging: metabolism /
Membrane Proteins: metabolism / aging (Other) / cell surface
proteins (Other) / cellular senescence (Other) / mass
spectrometry (Other) / senotherapeutics (Other) /
Senotherapeutics (NLM Chemicals) / Membrane Proteins (NLM
Chemicals)},
cin = {AG Ehninger / AG Bano},
ddc = {610},
cid = {I:(DE-2719)1013005 / I:(DE-2719)1013003},
pnm = {352 - Disease Mechanisms (POF4-352) / 351 - Brain Function
(POF4-351)},
pid = {G:(DE-HGF)POF4-352 / G:(DE-HGF)POF4-351},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39228130},
pmc = {pmc:PMC11634743},
doi = {10.1111/acel.14312},
url = {https://pub.dzne.de/record/273937},
}